Sven has more than 25 years of experience as a Senior Study Director LabCorp’s Early Development Services group, based in Münster, Germany. During his tenure, Dr. Korte oversaw sponsor engagement and study execution of more than 220 studies and has become a globally recognized key opinion leader in preclinical safety assessment across a wide range of therapeutic modalities, with extensive expertise in antisense oligonucleotides and gene therapy products using nonhuman primates (NHP). Dr. Korte has participated in more than 110 professional publications and lectured at numerous research symposiums and congresses across the globe. In addition, he has contributed to several books on the role of NHPs in drug development and was the co-editor of “The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment.”